Both were on a weight-loss injection at the time
Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover
*Correspondence: Louise Cominato, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
reported decreased IL-34 expression in thyroid tissue and serum, which correlated negatively with anti-Tg and anti-TPO antibody levels, and appeared to mitigate apoptotic severity
Tirzepatide: A Dual-Action Star SURMOUNT-1 Trial People on tirzepatide lost up to 20.9% of their body weight after 72 weeks
This article explores real-world trends in GLP-1 treatment adherence, reviews why patients discontinue therapy, and outlines practical ways clinicians can support persistence and improve long-term outcomes